As they say 'follow the money'
Gilead sets pricing for coronavirus drug remdesivir, could cost over $3G
In an open letter obtained by Fox News, Gilead Sciences CEO and Chairman Daniel O'Day said the price per vial of remdesivir would be $390 for government health care programs in developed countries, such as Medicare, equal to $2,340 per patient on a short, six-vial treatment.
For private insurance companies, the price would be $520 per vial, or $3,120 for a six-vial treatment.
https://www.foxnews.com/science/gilead-sets-coronavirus-drug-remdesivir-price